Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.
Transforming from our price-based sourcing model to a value-based approach requires the sharing of goals and collaborative effort from all stakeholders – doctors, patients, procurement professionals, MedTech professions.
In this AHJ interview William Downey, Customer Solutions Partner ANZ, Johnson & Johnson Medical talks about working with Dr John Rooney, Head of Orthopaedics, St Vincents Hospital, Sydney and Sarah Sweeney, Operational Transformation & Service Innovation Manager, St Vincents Hospital Network, Sydney, on how St Vincents Hospital Network, implemented Value Based Procurement by working with a MedTech supplier and for the ultimately benefit to the patient.
-
Analogy of the system, rather than the ED front door
“The problem of blockages shows up in ambulance ramping and long wait times, but this is a complex issue requiring whole-of-health system solutions,” according to Professor Hugh Grantham, Chair of Emergency Medicine Foundation in an interview with Australian Health Journal.
-
Enriching experiences in nursing mentorship
Mentoring in nursing is crucial for the development of nurses and the advancement of the nursing profession. It provides a supportive environment for personal and professional growth, knowledge transfer, and leadership development.
Australian Health Journal met with two nurses both working in Queensland, one the mentor, the other, the mentee. Both get to appreciate the experiences mentorship gives them.
-
WA and QLD RSV Immunisation programs show drops in infant hospitalisations
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
